Medhelp Care Aktiebolag Future Growth
Future criteria checks 5/6
Medhelp Care Aktiebolag is forecast to grow earnings and revenue by 76.1% and 13.9% per annum respectively. EPS is expected to grow by 76.1% per annum. Return on equity is forecast to be 38.5% in 3 years.
Key information
76.1%
Earnings growth rate
76.1%
EPS growth rate
Healthcare Services earnings growth | 28.8% |
Revenue growth rate | 13.9% |
Future return on equity | 38.5% |
Analyst coverage | Low |
Last updated | 15 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 138 | 19 | 18 | 31 | 1 |
12/31/2025 | 120 | 14 | 11 | 23 | 1 |
12/31/2024 | 105 | 7 | 7 | 18 | 1 |
12/31/2023 | 90 | -11 | -1 | 9 | N/A |
9/30/2023 | 90 | -3 | -4 | 7 | N/A |
6/30/2023 | 90 | -2 | -5 | 7 | N/A |
3/31/2023 | 89 | -4 | -25 | -14 | N/A |
12/31/2022 | 87 | -8 | -30 | -17 | N/A |
9/30/2022 | 84 | -14 | -33 | -23 | N/A |
6/30/2022 | 84 | -15 | -32 | -20 | N/A |
3/31/2022 | 84 | -11 | -13 | 1 | N/A |
12/31/2021 | 81 | -8 | -7 | 7 | N/A |
9/30/2021 | 79 | -3 | -4 | 8 | N/A |
6/30/2021 | 77 | -6 | -4 | 4 | N/A |
3/31/2021 | 75 | -5 | 0 | 9 | N/A |
12/31/2020 | 76 | -1 | 0 | 11 | N/A |
12/31/2019 | 62 | 5 | N/A | N/A | N/A |
12/31/2018 | 59 | 0 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 8L7 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.6%).
Earnings vs Market: 8L7 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 8L7 is expected to become profitable in the next 3 years.
Revenue vs Market: 8L7's revenue (13.9% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: 8L7's revenue (13.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 8L7's Return on Equity is forecast to be high in 3 years time (38.5%)